Universe Pharmaceuticals (UPC) Short term Debt (2020 - 2025)
Historic Short term Debt for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $446.5 billion.
- Universe Pharmaceuticals' Short term Debt fell 9352.89% to $446.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $446.5 billion, marking a year-over-year decrease of 9352.89%. This contributed to the annual value of $446.5 billion for FY2025, which is 9352.89% down from last year.
- According to the latest figures from Q3 2025, Universe Pharmaceuticals' Short term Debt is $446.5 billion, which was down 9352.89% from $6900.6 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Short term Debt's 5-year high stood at $6900.6 billion during Q3 2024, with a 5-year trough of $7293.0 in Q1 2022.
- Its 5-year average for Short term Debt is $918.4 billion, with a median of $5.5 million in 2023.
- Per our database at Business Quant, Universe Pharmaceuticals' Short term Debt tumbled by 10000.0% in 2021 and then skyrocketed by 12586655538.22% in 2024.
- Universe Pharmaceuticals' Short term Debt (Quarter) stood at $19723.0 in 2021, then surged by 17033.62% to $3.4 million in 2022, then skyrocketed by 62.24% to $5.5 million in 2023, then surged by 125866555.38% to $6900.6 billion in 2024, then tumbled by 93.53% to $446.5 billion in 2025.
- Its Short term Debt was $446.5 billion in Q3 2025, compared to $6900.6 billion in Q3 2024 and $5.5 million in Q1 2024.